Latest filing published 18 Dec 2018 for Ocular Therapeutix, INC, €48k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -16.4%Entry US$4.69 · Close at T+365 US$3.92
- -28.0%Entry US$5.64 · Close at T+365 US$4.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin F. Hanley: trading record in brief
This profile gathers the share dealings of Kevin F. Hanley in Ocular Therapeutix, Inc. Between 10 December 2018 and 14 December 2018, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €98k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 18 December 2018 came the latest disclosure, an open-market purchase for €48k in Ocular Therapeutix, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kevin F. Hanley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$5.5049.6% of flowCommon StockSEC:0001104659-18-073444:0Canonical exit: 14 Mar 2019 (T+90)
- 10,000 shares@ US$5.6050.4% of flowCommon StockSEC:0001104659-18-072563:0Canonical exit: 10 Mar 2019 (T+90)
2 of 2 declarations
